- Home
- CNSP vs BDRX Comparison
CNSP vs BDRX Comparison
Compare CNSP & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- BDRX
- Stock Information
- Founded
- CNSP 2017
- BDRX 2000
- Country
- CNSP United States
- BDRX United Kingdom
- Employees
- CNSP N/A
- BDRX N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- CNSP Health Care
- BDRX Health Care
- Exchange
- CNSP Nasdaq
- BDRX Nasdaq
- Market Cap
- CNSP 5.6M
- BDRX 5.8M
- IPO Year
- CNSP 2019
- BDRX N/A
- Fundamental
- Price
- CNSP $8.82
- BDRX $0.88
- Analyst Decision
- CNSP Hold
- BDRX
- Analyst Count
- CNSP 1
- BDRX 0
- Target Price
- CNSP N/A
- BDRX N/A
- AVG Volume (30 Days)
- CNSP 27.0K
- BDRX 1.3M
- Earning Date
- CNSP 08-13-2025
- BDRX 04-11-2025
- Dividend Yield
- CNSP N/A
- BDRX N/A
- EPS Growth
- CNSP N/A
- BDRX N/A
- EPS
- CNSP N/A
- BDRX N/A
- Revenue
- CNSP N/A
- BDRX N/A
- Revenue This Year
- CNSP N/A
- BDRX N/A
- Revenue Next Year
- CNSP N/A
- BDRX N/A
- P/E Ratio
- CNSP N/A
- BDRX N/A
- Revenue Growth
- CNSP N/A
- BDRX N/A
- 52 Week Low
- CNSP $7.72
- BDRX $0.78
- 52 Week High
- CNSP $744.00
- BDRX $19.75
- Technical
- Relative Strength Index (RSI)
- CNSP 37.72
- BDRX 44.57
- Support Level
- CNSP $7.72
- BDRX $0.84
- Resistance Level
- CNSP $9.62
- BDRX $0.95
- Average True Range (ATR)
- CNSP 0.86
- BDRX 0.09
- MACD
- CNSP -0.13
- BDRX 0.01
- Stochastic Oscillator
- CNSP 29.99
- BDRX 15.09
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.